发明名称 Method for producing circular or multimeric protein species in vivo or in vitro and related methods
摘要 A method is disclosed for the in vitro or in vivo cyclization of protein or peptide sequences. Also disclosed is a method of fusing polypeptide sequences while bound to a solid support These protein manipulation techniques relied on the trans-splicing activity of a split intein such as the naturally occuring split intein form the DnaE gene of Synechocysil sp. PCC6803 (Ssp DnaE intein). The cyclization procedures required the fusion of C- and N-terminal intern splicing domains to the N- and C-termini, respectively, of a target protein (Ineinc-target protein-InteinN). Cyclization in vivo occurred post-translationally when the two complementary intein splicing domains ligated the N- and C-terminus of the target protein. In vitro cyclization also utilized and InteinC-target protein-InteinN precursor protein, in which the intein domains were fused to a chitin binding domain (CBD). Protein expression was conducted under conditions that favored the accumulation of precursor protein. which was imnmobilized on a chitin resin. The circular protein species were eluted from the chitin resin following incubation under conditions that favored protein splicing. Trams-splicing was used to ligate polypeptides on a solid support by generating a protein composed of a CBD fused to a C-terminal intern splicing domain and target protein (1). This was incubated with a protein composed of target protein (2) fused to an N-terminal intein splicing domain and a CBD. The precursor proteins were immobilized on a chitin resin where trans-splicing resulted in the ligation of target protein (1) to target protein (2). These techniques greatly expand the procedures available for protein engineering and modification.
申请公布号 US2003013148(A1) 申请公布日期 2003.01.16
申请号 US20020937070 申请日期 2002.01.29
申请人 EVANS THOMAS C.;XU MING-QUN 发明人 EVANS THOMAS C.;XU MING-QUN
分类号 C07K14/195;C07K14/47;C07K19/00;(IPC1-7):C12P21/06;C12N5/06;C12N15/00 主分类号 C07K14/195
代理机构 代理人
主权项
地址